.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,536,743

« Back to Dashboard

Summary for Patent: 5,536,743

Title: Intravaginal treatment of vaginal infections with buffered metronidazole compositions
Abstract:A non-flowing composition and method for treatment of bacterial vaginosis are disclosed. An afflicted vagina is treated with a therapeutically effective but relatively low dose of metronidazole in a composition that includes a buffer system maintaining the composition at a pH value in the range of about 3.75 to about 4.25. The composition can also be used for prophylactic purposes.
Inventor(s): Borgman; Robert J. (Mundelein, IL)
Assignee: Curatek Pharmaceuticals Limited Partnership (Elk Grove Village, IL)
Application Number:08/295,242
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Formulation;
Patent PDF download available with subscription

No matches for this query

International Patent Family for Patent: 5,536,743

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria103176<disabled in preview>
Austria103813<disabled in preview>
Australia3043289<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc